Horizon Pharma (HZNP) IPO Prices at $9, Below Expected Range
Tweet
Share
E-mailGet Alerts HZNP Hot Sheet
Join SI Premium – FREE
Horizon Pharma, Inc. (Nasdaq: HZNP) priced its initial public 5.5 million share at $9 per share, below the expected $10-$12 range. Shares are expected to open on NASDAQ at approximately 11:20AM ET.
The offering is being made through Stifel Nicolaus Weisel, Cowen and Company, and JMP Securities.
Horizon Pharma a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
The offering is being made through Stifel Nicolaus Weisel, Cowen and Company, and JMP Securities.
Horizon Pharma a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bang Mai Fang files for 5M share IPO at $5-$6/sh
- Celcuity Inc (CELC) PT Lowered to $150 at Stifel as Gedatolisib Distribution Initiated
- Zentalis Pharmaceuticals prices $80.5M public stock offering
Create E-mail Alert Related Categories
IPOsRelated Entities
Stifel, JMP Securities, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
